VA-TEXT TD VHA GUIDANCE-PREGNANCY (10538)    REMINDER DIALOG (801.41)

Name Value
NAME VA-TEXT TD VHA GUIDANCE-PREGNANCY
CLASS NATIONAL
SPONSOR NATIONAL CENTER FOR HEALTH PROMOTION AND DISEASE PREVENTION (NCP)
EDIT HISTORY
  • EDIT DATE:   2016-05-23 13:06:30
    EDIT BY:   USER,FIFTYFOUR
    EDIT COMMENTS:   
    Exchange Install
    
RESOLUTION TYPE OTHER
EXCLUDE FROM PROGRESS NOTE NO
DIALOG/PROGRESS NOTE TEXT
Health care providers should administer Tdap during each pregnancy, 
first dose as a precaution). The recommended schedule is 0, 4 weeks, and 
6 to 12 months. Tdap should replace 1 dose of Td, preferably during the 
third trimester (between 27-36 weeks gestation) of pregnancy.
 
The Advisory Committee on Immunization Practices (ACIP)
states that although no evidence exists that tetanus and diphtheria
toxoids are teratogenic, waiting until the second trimester of pregnancy
to administer a routine Td booster is a reasonable precaution for
minimizing any concern about the theoretical possibility of such
reactions.
preferably during the third trimester (between 27-36 weeks gestation), 
although Tdap may be given at any time during pregnancy.  If Tdap is not 
administered during pregnancy, Tdap should be administered immediately 
postpartum.
 
Pregnant women who have never been vaccinated against tetanus should 
receive 3 doses of vaccine containing tetanus and reduced diphtheria 
toxoids (again waiting until the second trimester of pregnancy for the 
TYPE dialog element
SUPPRESS CHECKBOX SUPPRESS